1.	Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EDOAGL-8725-001, A5921009, NCT00068952
2.	Phase II Study of Edotecarin in Women With Anthracycline- and Taxane-Refractory or Chemoresistant Locally Advanced or Metastatic Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-03056, PHARMACIA-EDOABC-4439-001, NCT00070031
3.	Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EDOAGA-6736-001, A5921008, NCT00087503
4.	Phase I Study of Edotecarin and Cisplatin in Patients With Advanced or Metastatic Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-03070, PHARMACIA-EDOAES-2730-001, NCT00072332